Nouvelles de la Bourse
Dernières actualités financières · Mis à jour Jul 15, 2026
Trump s'entretient avec l'émir du Qatar alors que la pression de paix sur l'Iran dirigée par le Pakistan s'intensifie
Trump Speaks With Qatar Emir As Pakistani-Led Iran Peace Push Intensifies
Despite a market rally driven by de-escalation hopes, panelists agree that the underlying geopolitical issues remain unresolved, making the 'risk-on' …
L'Ukraine Utilise Des Ballons À Grande Altitude Pour Étendre la Portée des Frappes de Drones Kamikazes
Ukraine Uses High-Altitude Balloons To Extend Suicide Drone Strike Range
While Ukraine's balloon-assisted Hornet drone launch extends range and conserves battery power, it introduces significant operational risks such as weather …
Explainer-De Meta à SpaceX : comment les actions à double classe maintiennent le contrôle des fondateurs
Explainer-From Meta to SpaceX: how dual-class shares keep founders in control
The panel generally agrees that SpaceX's dual-class structure, with Musk's extreme voting power, poses significant risks for public investors. While …
J’ai 60 ans, j’ai 1,5 million de dollars d’économisés pour la retraite, et je déteste mon travail. Dois-je lui donner « juste un an de plus » ou démissionner maintenant ?
I’m 60 years old with $1.5M saved for retirement, and I hate my job. Should I give it ‘just one more year’ or quit now?
The panel consensus is that the article oversimplifies retirement planning, glossing over significant risks such as sequence-of-returns risk, healthcare cost …
Leerink Augmente son Objectif de Prix sur BeOne Medicines (ONC)
Leerink Raises its Price Target on BeOne Medicines (ONC)
The panel is divided on the significance of BeOne Medicines' FDA accelerated approval of Beqalzi (sonrotoclax) for relapsed/refractory mantle cell …
Morgan Stanley relève son objectif de prix pour Jazz Pharmaceuticals (JAZZ)
Morgan Stanley Raises its Price Target on Jazz Pharmaceuticals (JAZZ)
Jazz Pharmaceuticals' Q1 beat and analyst price target increases signal optimism about its pivot to a biotech-led growth story, but …
Evercore ISI relève sa cible de prix sur argenx (ARGX)
Evercore ISI Raises its Price Target on argenx (ARGX)
The panel is divided on the significance of argenx's FDA label expansion for Vyvgart. While some see it as a …
nVent Electric (NVT) Autorise un Nouveau Programme de Rachat d'Actions de 500 $M
nVent Electric (NVT) Authorizes New $500M Share Repurchase Program
The panel's discussion on NVT's $500M buyback authorization is mixed, with concerns about timing, valuation, and potential crowding out of …
Cimpress (CMPR) va acquérir SAXOPRINT et viaprinto auprès de CEWE
Cimpress (CMPR) to Acquire SAXOPRINT and viaprinto from CEWE
The panel is generally bearish on Cimpress's acquisition of SAXOPRINT and viaprinto, citing low margins, integration risks, and potential opportunity …
IBM vient de marquer un coup de pouce quantique de 26 milliards de dollars — et le rallye de l'action n'est pas terminé
IBM just scored a $26 billion quantum windfall — and the stock's rally isn't over
The panel is divided on IBM's $1B CHIPS grant for its Albany 300mm quantum foundry. While some see it as …
Cette action d'infrastructure IA est en hausse de 570% en 1 an. Est-il temps de prendre des bénéfices ou d'acheter plus?
This AI Infrastructure Stock Is Up 570% in 1 Year. Is It Time to Take Profits or Buy More?
Despite a correction in Ciena's stock gain, the panel remains cautious due to potential margin compression from a shift in …
Notre portefeuille de 100 000 $ d'actions de premier ordre rapporte 6 500 $ par an et offre aux baby-boomers un revenu passif important
Our $100,000 Blue-Chip Value Portfolio Pays $6,500 per Year and Offers Boomers Big Passive Income
The panel consensus is bearish on a $100k, five-name dividend portfolio (MO, ET, GIS, UPS, VZ) targeting ~6.5k in annual …